SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001209191-21-053224
Filing Date
2021-08-24
Accepted
2021-08-24 18:25:47
Documents
1
Period of Report
2020-11-20

Document Format Files

Seq Description Document Type Size
1 FORM 4/A SUBMISSION doc4a.html 4/A  
1 FORM 4/A SUBMISSION doc4a.xml 4/A 4332
  Complete submission text file 0001209191-21-053224.txt   5875
Mailing Address 35 PARKWOOD DRIVE BABRAHAM RESEARCH CAMPUS CAMBRIDGE X0 CB22 3AT
Business Address 35 PARKWOOD DRIVE BABRAHAM RESEARCH CAMPUS CAMBRIDGE X0 CB22 3AT 44 1223 497400
F-star Therapeutics, Inc. (Issuer) CIK: 0001566373 (see all company filings)

IRS No.: 522386345 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O EDDEVA B920 BABRAHAM RESEARCH CAMPUS CAMBRIDGE X0 CB22 3AT
Business Address
Kayitalire Louis (Reporting) CIK: 0001831519 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-37718 | Film No.: 211203195